Sell 10/17/2023Downgrade
Estrella Immunopharma, Inc. (ESLA) was downgraded to E+ from D- on 10/17/2023 due to a decline in the total return index, volatility index and efficiency index. Total capital declined 65.39% from -$4.06M to -$6.72M.

Sell 10/9/2023None
Estrella Immunopharma, Inc. (ESLA) was downgraded to D- from U on 10/09/2023.